To determine whether endotoxin causes histologic changes in the gallbladder consistent with acalculous cholecystitis, and to determine the effects of endotoxin on gallbladder motility.
Objective
To determine whether endotoxin causes histologic changes in the gallbladder consistent with acalculous cholecystitis, and to determine the effects of endotoxin on gallbladder motility.
Summary Background Data
Acute acalculous cholecystitis is frequently seen in critically ill, septic patients, after prolonged fasting and gallbladder stasis. The pathogenesis of acalculous cholecystitis is unknown; however, previous studies have suggested that ischemia may play a role.
Methods
Adult opossums received Escherichia coli lipopolysaccharide. The gallbladder was removed for histologic examination or for physiologic studies 4 hours to 2 weeks later. For histologic examination, gallbladder strips underwent standard hematoxylin-and-eosin processing. For physiologic studies, they were mounted in a tissue bath to determine responses to cholecystokinin octapeptide or electrical field stimulation.
Results
Intravenous endotoxin at a dose of 0.005 mg/kg resulted in disrupted mucosal surfaces and areas of hemorrhage; higher doses of endotoxin resulted in coagulation necrosis, hemorrhage, areas of fibrin deposition, and extensive mucosal loss, consistent with an acute ischemic insult. Endotoxin abolished the contractile response to cholecystokinin octapeptide in gallbladder strips 4 hours after endotoxin administration. The 0.005-mg/kg dose of endotoxin decreased the contractile response to cholecystokinin octapeptide for up to 96 hours after endotoxin administration and decreased the contractile response to electrical field stimulation for 48 hours after administration. Inhibition of nitric oxide synthase reversed the decreased contractile response to cholecystokinin octapeptide.
Conclusions
Endotoxin causes an ischemic insult to the gallbladder similar to that seen in acalculous cholecystitis. Also, endotoxin may lead to gallbladder stasis by decreasing gallbladder contractile responses to hormonal and neural stimuli.
Acute acalculous cholecystitis is a common accompaniment to multiple system organ failure and may be an important source of sepsis that is reversible. 1 Lipopolysaccharide impairs bile acid and organic anion hepatic transport, 2 but alterations in gallbladder function that may contribute to the jaundice and the cholestasis of sepsis are unknown. Although the upper gastrointestinal tract is relatively bacteria-free, bacterial overgrowth could potentially occur in the setting of impaired gallbladder motility. Changes in the biliary tract flora, coupled with impairment of the normal barrier function, allow the gallbladder to serve as a reservoir for pathogens that can enter the portal and systemic circulations. Enteral nutrition decreases the rates of nosocomial infections 3, 4 ; however, the gastrointestinal function of critically ill patients is frequently not adequate to permit enteral nutrition because of gastric and small intestinal ileus resulting from sepsis. Total parenteral nutrition, which has been found to be a contributing factor for acalculous cholecystitis, 5, 6 is then needed to support the patient.
Acalculous cholecystitis is being diagnosed with increasing frequency in critically ill, septic patients and typically occurs in conditions associated with biliary stasis, including major surgery, severe trauma and sepsis, long-term total parenteral nutrition, and prolonged fasting. 7 The pathogenesis of acute acalculous cholecystitis is unknown; however, some authors have suggested that ischemia or reperfusion injury may play a role. 8 Impaired gallbladder emptying has been thought to be a key factor leading to inspissation of bile and sludge formation. 9, 10 The marked gallbladder hypomotility in these conditions may make diagnosis of the acalculous cholecystitis difficult. Serial ultrasonography in septic patients has demonstrated a characteristic ultrasonographic appearance of gallbladder enlargement, boggy thickening of the wall, and biliary sludge. 1 The aims of our study were to determine whether endotoxin causes histologic changes in the gallbladder similar to the ischemic insult that occurs during acalculous cholecystitis and to determine the effects of endotoxin on gallbladder motility. We hypothesized that endotoxemia causes histologic changes in the gallbladder consistent with an ischemic injury, which may lead to changes in motor function. We also hypothesized that endotoxemia results in impaired neuromuscular changes in vitro that may lead to diminished gallbladder motility and impaired emptying. Finally, we hypothesized that increased nitric oxide production in response to the endotoxemia may be a mechanism that produces gallbladder smooth muscle relaxation.
METHODS

Preparation of Animals
Adult opossums (Didelphis virginia) of either sex weighing 3 to 6 kg were fasted overnight and then anesthetized with ketamine (30 mg/kg)/acepromazine (0.3 mg/kg) given intramuscularly and sodium pentobarbital (50 mg/kg) given intraperitoneally. Intravenous access was obtained by means of the right internal jugular vein, and the animals received either 0.9% NaCl (1 mL given intravenously) or E. coli lipopolysaccharide (serotype 055:B5, Sigma Chemical, St. Louis, MO) in a dose of 0.005, 0.05, or 0.50 mg/kg given intravenously. The animals were then allowed to recover and were given free access to food and water. Animals receiving 0.005 mg/kg were anesthetized at 4 hours or 1, 2, 3, 4, or 14 days later with ketamine (30 mg/kg)/ acepromazine (0.3 mg/kg) given intramuscularly and sodium pentobarbital (50 mg/kg) given intraperitoneally. The gallbladder was removed for physiologic studies and the animal was killed. In additional studies, opossums receiving saline or any of the three doses of lipopolysaccharide were anesthetized 4 hours later and the gallbladder was removed for histologic examination. All procedures were carried out according to the protocol approved by the Department of Veterans Affairs and the University of Iowa Animal Care and Use Committees. Surgical procedures and experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals of the Public Health Service.
Conduct of Tests
For physiologic studies, the gallbladder was opened as a flat sheet and full-thickness strips approximately 2 ϫ 7 mm were cut. Care was taken to cut strips of the same length and width. The strips were placed in 5-mL organ baths and mounted to record smooth muscle contractions. Gallbladder strips were stimulated by either electrical field stimulation (EFS), to determine their response to intrinsic nerve stimulation, or the addition of cholecystokinin-8. The organ baths contained Krebs solution (consisting of [in mmol/L] 138.5 sodium, 4.6 potassium, 2.5 calcium, 1.2 magnesium, 125 chloride, 21.9 bicarbonate, 1.2 phosphate, 1.2 sulfate, and 11.5 glucose) and were maintained at 37°C and gassed with 95% O 2 /5% CO 2 . Specimens were stretched to an initial tension of 0.4 mg, and the strips were allowed to equilibrate for 60 minutes. EFS was delivered by using 8-Hz stimulation with 0.1-msec pulses for 5 seconds delivered at 1-minute intervals using 70 volts from a Grass S48 stimulator (Grass Instruments, Quincy, MA). The response to EFS was quantified by measuring the amplitude of the off response. This electrical stimulus is known to produce nearmaximal nerve-mediated response. 11 It releases nitric oxide from intrinsic gut motor nerves and produces a nervemediated contraction, the off response, after the end of each train. 12, 13 In other smooth muscle strips from the gallbladder, a dose-response curve was generated by adding cholecystokinin-8 (Sigma Chemical) stepwise to the organ bath to obtain final concentrations of 1.5 ϫ 10 Ϫ11 to 3 ϫ 10 Ϫ5 mol/L. In additional experiments, the contribution of nitric oxide to decreased responsiveness of cholecystokinin-8 was determined. Dose-responses to cholecystokinin-8 were determined; if there was no response or a blunted contractile response, even at the highest doses, N G -nitro-L-arginine (L-NNA), 0.1 to 1.0 mol/L, was added to the tissue bath for 5 minutes, and dose-responses to cholecystokinin-8 were repeated. After determining the dose-response relationship, each strip was measured, blotted lightly, and weighed. The cross-sectional area of each strip was calculated from length and weight data by assuming that the density of smooth muscle was 1.05 g/cm 3 . All active contractile force was normalized to the cross-sectional area and was expressed as force (g/cm 3 ). 14 Such normalization can correct for any differences in tension development that are due simply to differences in the size of the strips, even though in the gallbladder, smooth muscle bundles intermingle and are not oriented in any preferential direction. 15 For both the EFS experiments and the dose-response to cholecystokinin-8 experiments, the output of the force displacement transducers was processed through a MacLab 8 analog-digital converter (ADInstruments, Inc., Milford, MA), recorded on a Macintosh IIcx computer (Apple Com-
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Histologic Examination
Gallbladders from each group of animals (n ϭ 4 per group: control, lipopolysaccharide 0.005, 0.05, and 0.5 mg/ kg) were removed at 4 hours for histologic examination. Briefly, the gallbladders were sectioned into longitudinal strips and placed in formaldehyde. The strips were embedded in paraffin, sectioned, and stained with hematoxylin and eosin for viewing under light microscopy by an experienced pathologist (F.A.M.).
Statistical Analysis
Analysis of variance with the Tukey test and the Wilcoxon rank-sum test for nonparametric data were used to determine differences in the treatment groups. Statistical significance of differences between groups was tested using the computer program SYSTAT (Evanston, IL). All data are expressed as means Ϯ standard error of the mean.
RESULTS
Histologic Examination
Endotoxin produced histologic changes consistent with an ischemic insult, similar to what is seen with acalculous cholecystitis. Four hours after administration of the larger doses of endotoxin (0.50 and 0.05 mg/kg), coagulation necrosis and hemorrhage, consistent with acute ischemic necrosis, were seen in histologic sections of the gallbladder (Fig. 1) . Also, there were areas of fibrin deposition and mucosal loss, also consistent with an ischemic insult. Four hours after administration of the lower dose of endotoxin (0.005 mg/kg), smaller areas of hemorrhage were seen and the mucosal surface was lost.
Physiologic Studies
Endotoxemia impaired the contractile response to cholecystokinin-8 (Fig. 2) . Compared with controls, animals receiving endotoxin had no response to cholecystokinin-8 until the highest doses of cholecystokinin-8 (1.5 ϫ 10 Ϫ5 mol/L) were used. For example, cholecystokinin-8 (1.5 ϫ 10 Ϫ7 mol/L) increased isometric tension in control gallbladder strips to 29.9 Ϯ 5.5 g/cm 3 but had little effect on muscle strips from endotoxemic animals, producing an increase in tension of less than 1.0 g/cm 3 (P Ͻ .01 vs. control). The lowest dose of endotoxin (0.005 mg/kg) disrupted the gallbladder contractile response to cholecystokinin-8 for 96 hours. Cholecystokinin-8 (1.5 ϫ 10 Ϫ8 mol/L) increased isometric tension in control gallbladder strips to 14.2 Ϯ 2.9 g/cm 3 . For 96 hours, the same dose of cholecystokinin 8 had little effect on isometric tension, increasing it to only 2.1 Ϯ 1.1 g/cm 3 . At 14 days after receiving endotoxin (0.005 mg/kg), the gallbladder muscle strips' response to cholecystokinin-8 increased to 10.4 Ϯ 6.2 g/cm 3 , which was similar to that found in the controls.
L-NNA (1 mol/L) reversed the decreased contractile response to cholecystokinin-8 48 hours after the endotoxin injection (0.005 mg/kg). In controls, cholecystokinin-8 (1.5 ϫ 10 Ϫ6 M) resulted in a large contraction of the gallbladder strips (Fig. 3 ). As mentioned above, endotoxin diminished this response for up to 4 days. However, in the presence of L-NNA, a competitive inhibitor of nitric oxide synthase, the contractile response to cholecystokinin-8 returned to control values. L-NNA had no effect on the gallbladder contractile response to cholecystokinin-8 during the rest of the endotoxemic study days and had no effect on cholecystokinin-8 contractile response in animals given the higher doses of endotoxin (0.5 or 0.05 mg/kg). Thus, increased nitric oxide production may play a role in the diminished gallbladder motility seen during endotoxemia.
Also, EFS-induced gallbladder contractions were decreased for 4 hours and 24 hours after endotoxin administration (0.005 mg/kg) ( Fig. 4) . EFS-induced changes in isometric tension were 22.5 g/cm 3 Ϯ 2.1 in controls but decreased to 5.5 g/cm 3 Ϯ 0.8 at 4 hours and 12.0 g/cm 3 Ϯ 2.1 at 24 hours (P Ͻ .05 vs. control). Nerve-mediated changes in isometric tension in endotoxemic animals at 48 hours were similar to controls.
DISCUSSION
Our study results demonstrate that endotoxin disrupts mucosal surfaces and causes areas of hemorrhage throughout the gallbladder. With increased doses of endotoxin, coagulation necrosis, hemorrhage, areas of fibrin deposition, and extensive mucosal loss are seen, consistent with an acute ischemic insult. Endotoxin abolishes the contractile response to cholecystokinin-8, whereas a low dose of endotoxin decreases the contractile response to cholecystokinin-8 for up to 96 hours and decreases the contractile response to EFS for 48 hours. Inhibition of nitric oxide synthase reverses the decreased contractile response to cholecystokinin-8. Endotoxin causes an ischemic insult to the gallbladder similar to that seen in acalculous cholecystitis. Also, the motility changes produced by endotoxemia may lead to gallbladder stasis by temporarily decreasing gallbladder contractile responses to hormonal and neural stimuli.
These data correspond with the results of previous studies from our laboratory 16, 17 and others 18, 19 regarding the effects of sepsis and endotoxemia on gastrointestinal motility. Eskandari et al 18, 19 demonstrated that endotoxin caused a 62% reduction in jejunal spontaneous circular muscle activity and a 91% suppression of bethanechol-stimulated contractions in the jejunum. Thus, endotoxin administration seems to result in smooth muscle impairment, even though the effects of endotoxin on gastrointestinal motility may not be due to decreased splanchnic perfusion. 16 The smallest dose of endotoxin (0.005 mg/kg) used in the current study is 2.5% the dose we have given to dogs 16 and 0.0005% the dose we have given to rats. 17 Our present study suggests that the gallbladder may be more sensitive to the effects of endotoxin than other areas of the gut, because a low dose of endotoxin produces profound changes in biliary tract motility for an extended period. In general, the opossums tolerated the lowest dose of endotoxin (0.005 mg/kg) even for up to 2 weeks. At the higher doses of endotoxin (0.05 to 0.5 mg/kg), the animals appeared more listless and had more areas of gross hemorrhage in the gallbladder lumen.
Calabuig et al 20 demonstrated a decrease in gallbladder emptying and a prolongation of the migrating myoelectric complex after hemorrhagic shock. Also, impairment of gallbladder smooth muscle contractility after hemorrhagic shock has been demonstrated in vitro. 21 In their study, decreased responses to cholecystokinin octapeptide and cholinergic agonists occurred in gallbladder smooth muscle strips after hemorrhagic shock. Thus, shock may impair gallbladder motility, leading to stasis and decreased emptying.
We recently demonstrated decreased bile acid secretion in dogs after an endotoxin bolus. 22 Bile secretion decreased for 1 day after the endotoxin bolus, although there were no changes in plasma cholecystokinin levels. These studies suggest that during endotoxemia, plasma levels of cholecystokinin change little; however, the gallbladder may be unresponsive to the effects of the gut hormone. Previous studies have demonstrated decreased bile acid synthesis during endotoxemia as a result of decreased transport of bile acids in hepatic cells. 23 Bolder et al 2 demonstrated decreased bile flow during endotoxemia, which was attributed to decreased secretion of bile acids. However, impaired canalicular bile formation, sphincter of Oddi dysfunction, or gallbladder hypomotility may also delay emptying of bile into the duodenum, which could potentially predispose to bacterial proliferation. Decreased bile flow and the subsequent decreased bile acid concentration in the small intestine may also occur, which may lead to translocation 24 and endotoxin absorption. 25 Thus, a vicious cycle may result, with increased endotoxin absorption caused by impaired biliary secretion and stasis in the gallbladder, which could in turn cause more endotoxin absorption.
Our study demonstrates that increased nitric oxide production may play a role in the decreased response of gallbladder smooth muscle to cholecystokinin-8 during endotoxemia. Application of a nonspecific nitric oxide synthase inhibitor restored the contraction response to cholecystokinin-8. The role of nitric oxide in mediating the smooth muscle dysfunction during endotoxemia has been demonstrated in several studies. Eskandari et al 26 demonstrated a reduction in circular smooth muscle activity after an endotoxin bolus that was reversed with in vitro application of a specific inducible nitric oxide synthase inhibitor. Weisbrodt et al 27 also reported that competitive inhibition of nitric oxide synthase reversed the lipopolysaccharide-induced suppression of rat longitudinal muscle activity. In gallbladder tissues not treated with endotoxin, Mourelle et al 28 demonstrated that competitive inhibition of nitric oxide synthase increased the gallbladder strips' contractile response to cholecystokinin-8.
Our study suggests that endotoxin causes changes in gallbladder motility and histology similar to what is seen during acute acalculous cholecystitis. Other experimental preparations have been proposed to mimic the clinical scenario of acalculous cholecystitis. Parkman et al 29, 30 have demonstrated gallbladder smooth muscle dysfunction after common bile duct ligation. This experimental preparation has been proposed to demonstrate the effects of acute acalculous cholecystitis because it reliably produces acute inflammation of the gallbladder. Also, the response of gall- bladder strips to potassium and bethanechol is decreased. Our experimental preparation of acalculous cholecystitis differs because bile flow is not impeded, but inflammation and motility changes occur. Clinical studies of acalculous cholecystitis have suggested the absence of obstruction of either the cystic duct or the common bile duct. 7, 9 The results of our histologic studies suggest that endotoxin causes an acute ischemic insult in the gallbladder, leading to coagulation necrosis, hemorrhage, areas of fibrin deposition, and extensive mucosal loss. At increased doses of endotoxin, coagulation necrosis, hemorrhage, areas of fibrin deposition, and extensive mucosal loss are seen, suggesting a dose-response effect of endotoxin on the gallbladder. Although we studied the effects of the larger doses of endotoxin (0.05-0.5 mg/kg) on the gallbladder contractile response to cholecystokinin-8 and EFS at only 4 hours after endotoxin administration, our results suggest that these larger doses of endotoxin may lead to an even greater physiologic impairment of cholecystokinin-8 or EFS than what was seen at the lower dose (0.005 mg/kg). The results of previous histologic studies in acalculous cholecystitis correlate with our findings. In a study comparing histologic findings with evidence of small vessel occlusion in gallbladders removed for acute acalculous cholecystitis, Warren 9 suggested that decreased splanchnic flow led to intravascular coagulation and necrosis in acalculous cholecystitis.
In conclusion, a single dose of endotoxin causes coagulation necrosis, hemorrhage, fibrin deposition, and extensive mucosal loss in the gallbladdder consistent with an acute ischemic insult similar to that seen in acalculous cholecystitis. Endotoxin abolishes the contractile response to cholecystokinin-8 for up to 96 hours and decreases nerve-mediated responses for 48 hours, which may lead to gallbladder stasis by temporarily decreasing the gallbladder contractile responses to hormonal and neural stimuli. Finally, nitric oxide may play a role in the motility changes in the gallbladder during endotoxemia, because inhibition of nitric oxide synthase reverses the decreased contractile response to cholecystokinin-8.
